2022 SVS VQI Annual Report is Now Available
The 2022 SVS VQI Annual Report is now available for download. You can review the news and highlights of the past year by clicking below to access.
The 2022 SVS VQI Annual Report is now available for download. You can review the news and highlights of the past year by clicking below to access.
Chicago, IL– June 14, 2022 – The Society for Vascular Surgery® Vascular Quality Initiative® (SVS VQI), a nonprofit organization dedicated to improving the quality of vascular care within hospitals and outpatient facilities, announces that the Centers for Medicare and Medicaid Services (CMS) has expanded coverage for Transcarotid Artery Revascularization (TCAR) to include…Read More
ATLANTA–(BUSINESS WIRE)–Fivos announces a strategic partnership with Cedaron Medical to expand participation in the Society for Vascular Surgery® Vascular Quality Initiative® (SVS VQI) by combining Fivos’ robust registry platform services with Cedaron’s data collection and management expertise.
Fivos provides national registry services…Read More
Organizations will work together to eliminate variances and data discrepancies and ensure hospitals meet FDA reporting requirements
Chicago, IL – September 28, 2021 – The Society for Vascular Surgery® Vascular Quality Initiative® (SVS VQI), a nonprofit organization dedicated to improving vascular quality within hospitals and outpatient facilities, today announced…Read More
Flagship program offered by The Society for Vascular Surgery® Vascular Quality Initiative® (SVS VQI) will focus on quality processes and data utilization among vascular surgery residents.
Chicago, IL– August 19, 2021 – The Society for Vascular Surgery® Vascular…Read More
The Society for Vascular Surgery® Vascular Quality Initiative® (SVS VQI) marks first decade with significant growth milestones
Chicago, IL and West Lebanon, NH – August 18, 2021 – The Society for Vascular Surgery® Vascular Quality Initiative® (SVS VQI), a nonprofit organization dedicated to improving vascular quality within hospitals and outpatient facilities, celebrates 10 years today….Read More
Medtronic is making updated patient management recommendations related to its voluntary recall of the Valiant Navion™ Thoracic Stent Graft on February 17th, which included the patient recommendation for physicians to follow best clinical practice and make best efforts to evaluate patients with at least annual follow-up according to the recommendations…Read More
Effective immediately the Participation Committee unanimously voted to re-instate LTFU criteria in the 2021 Participation Awards. During the height of the 2020 COVID-19 pandemic, the committee decided to temporarily remove LTFU as criteria for the 2020 Participation Awards. Now that centers have implemented sustainable measures to address COVID-19’s impact (re-assigning…Read More
The SVS PSO would like to make you aware that the FDA has published an update to the 2020 December Safety Communication regarding their intention to convene an Advisory Committee Meeting in 2021. As indicated in the update, the FDA plans to hold a virtual two-day meeting of the…Read More
Feb. 17, 2021 – Medtronic plc (NYSE:MDT), the global leader in medical technology, has voluntarily issued a global recall of unused Medtronic Valiant Navion™ thoracic stent graft system and informed physicians to immediately cease use of the device until further notice.
In accordance with its commitment to patient safety – and…Read More